Marna Williams,J. Yun Tso,Nicholas F. Landolfi,Gao Liu
申请号:
US13894857
公开号:
US20140065063A1
申请日:
2013.05.15
申请国别(地区):
US
年份:
2014
代理人:
摘要:
The present invention is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The invention also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present invention also provides for a method of preventing or treating disease states, including autoimmune disorders and cancer, in a subject in need thereof, comprising administering into said subject an effective amount of such antagonists.